Repeat Dosing Study Demonstrates Positive Data for Neffy Epinephrine Nasal Spray
Drug Topics
FEBRUARY 23, 2024
Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.
Fri.Feb 23, 2024
232 
The Pharmacy Industry Then and Now: How the Field Has Evolved Over Time
Pharmacy Times
FEBRUARY 23, 2024
The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Breakthrough Vaccine for Chronic Hepatitis B Enters First In-Human Trial
Drug Topics
FEBRUARY 23, 2024
With over 3% of the world’s population affected by chronic hepatitis B, TherVacB has the potential to address a critical unmet need for a cure.
STAT+: UnitedHealth cyberattack cripples pharmacies’ and hospitals’ ability to process insurance claims
STAT
FEBRUARY 23, 2024
Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam after UnitedHealth Group disclosed a cyberattack within a recently acquired subsidiary that serves as a central hub for payments across the industry. The cyberattack and subsequent system outage within UnitedHealth’s Change Healthcare has caught the attention of federal law enforcement agencies.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How Technology Has Changed the Pharmacy Landscape
Drug Topics
FEBRUARY 23, 2024
During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy.
Pharmacists Play Vital Role in Improving Vaccine Equity
Pharmacy Times
FEBRUARY 23, 2024
Investing in community relationships and health literacy are key steps pharmacists can take to improve equity.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Veterans Mental Health Care Improvement Act of 2019 Expands Access
Pharmacy Times
FEBRUARY 23, 2024
Four years after congress passed it, the Hannon Act is helping veterans get better care
As midwife-assisted home births rise, so too do high-risk births outside hospitals
STAT
FEBRUARY 23, 2024
Kay Kay Lineweaver’s first birthing experience in 2021 didn’t go as planned. Her baby was breech and the doctor wouldn’t allow her to try to give birth vaginally, so she ended up with an unwanted cesarean section. “[The obstetrician] wouldn’t even give me the option,” she recalled later in a podcast called “Healing Trauma Mamas.
Telepharmacy Services Can Help Pharmacists Streamline Workflows, Improve Patient Outcomes
Drug Topics
FEBRUARY 23, 2024
Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed how technological solutions can aid pharmacies during a session at the Outcomes 2024 SYNC National Conference in Orlando, Florida.
STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado
STAT
FEBRUARY 23, 2024
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed Amgen drug used to treat arthritis, a step that may usher in a new era in which state governments take more aggressive action to control the cost of prescription medicines.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Travere's Filspari, J&J's Carvykti win support from CHMP in blitz of positive recommendations
Fierce Pharma
FEBRUARY 23, 2024
A narrow miss in a confirmatory trial has | Along with host of other positive recommendations, European drug regulators rendered a positive opinion on Travere's Filspari for full approval in Berger’s disease.
Bavarian Nordic gets swift EU review of chikungunya shot
pharmaphorum
FEBRUARY 23, 2024
Bavarian Nordic will get an accelerated review of its chikungunya vaccine CHIKV VLP at the EMA, as it tries to chase down a lead held by rival Valneva. The Danish pharma group said it is planning to file for approval of its vaccine in the first half of this year, adding the EU regulator’s human medicine committee, the CHMP, has said it will cut the review time from 210 to 150 days under its accelerated assessment procedure.
To BioMarin CEO Alexander Hardy, hemophilia A gene therapy Roctavian needs 3 stars to align
Fierce Pharma
FEBRUARY 23, 2024
Even Alexander Hardy, the former Genentech leader who managed the blockbuster hemophilia drug Hemlibra, can’t immediately bend the laggard launch trajectory of BioMarin’s gene therapy Roctavian.
Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
Pharmacy Times
FEBRUARY 23, 2024
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Medicare Advantage fraud in DOJ's crosshairs after agency reports $2.7 billion in settlements
Fierce Healthcare
FEBRUARY 23, 2024
Under the False Claims Act, more than $1.8 billion in settlements and judgments was related to health-related matters in the last fiscal year, about two-thirds of the monetary fraud recoveries by t | Health fraud settlements under the False Claims Act exceeded $1.8 billion last year, according to the Department of Justice. The agency said it is still litigating Medicare Advantage cases against major insurers.
Generation next: Capturing millennial, Gen Z shoppers
Drug Store News
FEBRUARY 23, 2024
How does retail pharmacy capture spending of millennials and Gen Z customers who seek convenience and digital connectivity?
Walgreens' VIllageMD exits Florida market, shuttering remaining primary care clinics
Fierce Healthcare
FEBRUARY 23, 2024
Walgreens is closing its remaining VillageMD primary care clinics in Florida. | The announcement does not come as a total surprise, as Walgreens first disclosed its plans to close 60 underperforming VillageMD clinics and exit five markets last fall.
Congressional lawmakers strike back at Biden admin's 'march-in' proposal to corral drug costs
Fierce Pharma
FEBRUARY 23, 2024
As the Biden administration’s exploration of “march-in rights" draws support from powerful entities like the Federal Trade Commission (FTC), a group of lawmakers on both sides of the aisle have war | As the Biden administration’s exploration of “march-in rights" draws support from powerful entities like the Federal Trade Commission, a small group of lawmakers on both sides of the aisle have warned the approach could “hamstring” U.S. innovation.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Despite sectorwide financial recovery, not all are hospitals are finding their footing
Fierce Healthcare
FEBRUARY 23, 2024
Broadly speaking, the hospital sector is a much stronger state financially than it was in 2022 or even early 2023 amid industry reports of higher medians and margin improvements being shared by sev | A review of hospitals' 2023 operating numbers show 40% are still losing money going into 2024 and that high-performing hospitals are "effectively pulling away from the pack," according to a recent Kaufman Hall analysis.
AI improves adenoma detection in colonoscopies
pharmaphorum
FEBRUARY 23, 2024
AI software developed by Israeli medtech Magentiq-Eye has been shown to improve detection rates for adenoma, a precursor to colorectal cancer, in colonoscopy procedures
After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge
Fierce Pharma
FEBRUARY 23, 2024
Teva and Alvotech have braved a long and winding road on the quest to win approval for their biosimilar to AbbVie’s Humira. | Teva and Alvotech have braved a long and winding road on the quest to win approval for their biosimilar to AbbVie’s Humira. Now, after multiple manufacturing setbacks, the partners have finally scored their inaugural regulatory nod in the United States.
STAT+: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more
STAT
FEBRUARY 23, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda appears quite modest so far. We plan to promenade with the official mascots, catch up on our napping and maybe finish an overdue library book. There might also be a listening party, and the rotation will likely include this , this , this , this and this.
Oncopeptides' Pepaxto reaches end of the line in US after FDA yanks approval
Fierce Pharma
FEBRUARY 23, 2024
Following a contentious advisory committee meeting and an FDA request for the withdrawal of Oncopeptides’ multiple myeloma drug Pepaxto from the U.S. | Following a contentious advisory committee meeting and an FDA request for withdrawal of Oncopeptides’ multiple myeloma drug Pepaxto from the U.S. market in late 2022, the other shoe has dropped.
In search of the fabled tricorder
pharmaphorum
FEBRUARY 23, 2024
In search of the legendary tricorder using cutting-edge AI and MedTech. Discover the future of healthcare technology today.
STAT+: Ocular Therapeutix moves in the right direction, and Alnylam tries to calm some nerves
STAT
FEBRUARY 23, 2024
This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks. A Worst CEO gets some much-needed help For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for de
Canviiy achieves 6K store milestone following Walgreens expansion
Drug Store News
FEBRUARY 23, 2024
Canviiy is now available at more than 6,000 retail stores following its recent Walgreens rollout.
STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional
STAT
FEBRUARY 23, 2024
In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription drug pricing. For now, the Oregon Department of Consumer and Business Services will no longer require drug companies to compile annual reports on price increases, a key feature of a transparency law that was enacted in 2018.
NCPA releases latest survey on drug supply chain, staffing
Drug Store News
FEBRUARY 23, 2024
Staffing in some independent pharmacies is continuing to be a challenge, with 67% saying it’s difficult to fill open staff positions, according to the NCPA survey.
FDA will decide in June on Dupixent for COPD
pharmaphorum
FEBRUARY 23, 2024
The FDA has started a priority review of Sanofi and Regeneron’s Dupixent as a treatment for chronic obstructive pulmonary disease (COPD), which could become the first new treatment for the widespread and life-threatening disease in over a decade.
Talkspace targets strong revenue growth in 2024 as it doubles down on payer, enterprise strategy
Fierce Healthcare
FEBRUARY 23, 2024
Online therapy company Talkspace is doubling down on its strategy to grow its business with payers and employers with a focus on providing services to teens and seniors. | Online therapy company Talkspace is doubling down on its strategy to grow its business with payers and employers with a focus on providing services to teens and seniors.
CVS adds Grubhub to same-day delivery services
Drug Store News
FEBRUARY 23, 2024
The retailer is now collaborating with Grubhub to offer an assortment of thousands of wellness, beauty, household and other convenience items on the Grubhub Marketplace.
What’s the best time to take ashwagandha?
The Checkup by Singlecare
FEBRUARY 23, 2024
Ashwagandha, also known as Indian winter cherry or Indian ginseng, is a relatively small, unassuming plant—an evergreen shrub with greenish-gray oval leaves. Yet, this herb holds a very important place in Ayurvedic medicine, a system of traditional medicine with deep roots in India that aims to prevent disease and keep the mind, body, and spirit in balance.
Teen entrepreneur creates Teja Immunity Gummies
Drug Store News
FEBRUARY 23, 2024
Teja, founded by Sriteja Kataru at 13 years old, offers supplements created by and for teens.
Let's personalize your content